Elo Mutual Pension Insurance Co Sells 502 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Elo Mutual Pension Insurance Co trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,840 shares of the company’s stock after selling 502 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in HCA Healthcare were worth $5,732,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. Royal Bank of Canada grew its stake in HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares during the period. Capital World Investors increased its stake in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares in the last quarter. Sanders Capital LLC lifted its stake in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after buying an additional 456,738 shares in the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth about $131,527,000. Finally, TD Asset Management Inc boosted its stake in HCA Healthcare by 230.5% during the 4th quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock valued at $149,747,000 after purchasing an additional 385,854 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $399.89 on Thursday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $404.90. The stock has a market capitalization of $104.74 billion, a P/E ratio of 19.93, a PEG ratio of 1.46 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm’s 50 day moving average is $367.24 and its 200 day moving average is $339.56.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company posted $4.29 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on HCA. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. UBS Group increased their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Finally, Leerink Partners boosted their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.